Johnson & Johnson
Johnson & Johnson's single-dose COVID-19 vaccine gets Emergency Use approval in India
The 5 vaccines granted EUA in India are SI's Covishield, Bharat Biotech's Covaxin, Russia's Sputnik V, Moderna and now Johnson & Johnson
Johnson & Johnson's single-dose vaccine shows promising signs against Delta variant
According to the company report, the vaccine generated strong, persistent activity against the Delta variant
India close to giving indemnity to foreign vaccine makers like Pfizer: Report
The government has already met one of Pfizer's other key demands by dropping a requirement that foreign vaccines undergo local trials
India's Biological E. to produce J&J COVID-19 vaccine
J&J confirmed to Reuters it was working with Biological E. on manufacturing its vaccine
Biden announces all Americans to be eligible for COVID-19 vaccination by May 1
The US is the worst-hit country with the world's highest number of cases and deaths at 29,150,068 and 529,102, respectively
Pressure mounts on Johnson & Johnson to halt sales of baby powder globally
Johnson & Johnson said in May it would stop sales in the US and Canada, saying demand had fallen in wake of what it called “misinformation”
Johnson & Johnson ordered to pay $2.1 billion over cancer-causing talc powder
Johnson & Johnson faced thousands of lawsuits across US alleging it failed to warn consumers of the risk of cancer from its talc products
Race for virus vaccine could leave some countries behind
Rich countries are rushing to place advance orders for the inevitably limited supply to guarantee their citizens get immunized first
Johnson & Johnson stops selling baby powder in US, Canada
J&J faces more than 16,000 lawsuits from consumers claiming its talc products, including Johnson's Baby Powder, caused their cancer
Human trials of Johnson & Johnson coronavirus vaccine to begin in September
US pharmaceutical Moderna has already moved into human trials for its vaccine candidate, as has China's CanSinoBIO.